C10orf88 Activators
Activators of C10orf88 encompass a diverse chemical class, primarily indirect activators, that influence various cellular signaling pathways and processes. These compounds are selected based on their known effects on cellular mechanisms that could conceivably impact the activity or expression of C10orf88, despite a lack of direct evidence linking them to the protein. They include growth factors, such as EGF, which engages with receptor tyrosine kinases to initiate signaling cascades that may modulate C10orf88. Metabolic regulators like metformin and AICAR can exert their influence on cellular energy balance, which could impinge upon C10orf88 if it is tied to metabolic control.
Cell cycle modulators such as roscovitine impact the progression and checkpoints of the cell cycle, altering the expression of proteins whose regulation is intertwined with these processes, including possibly C10orf88. Epigenetic modulators like sodium butyrate and BIX-01294 affect chromatin accessibility and gene transcription, offering routes to modify the expression levels of C10orf88 if its gene is subject to such regulation. Lastly, intracellular signaling molecules such as db-cAMP and TPA, which activate kinases like PKA and PKC, have the capacity to alter the activity of numerous proteins. If C10orf88 is a downstream effector of these pathways, these molecules can serve as indirect activators. Collectively, these activators operate across various biological pathways, highlighting the intricate web of intracellular signaling that converge on the modulation of C10orf88.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin interacts with its receptor to activate the PI3K/Akt signaling pathway. Activation of Akt can lead to the phosphorylation and inactivation of GSK-3β, potentially increasing the stability and activity of proteins downstream, which may include C10orf88 if it is a substrate. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMPK, which can inhibit mTOR signaling. This alteration in cellular energy status can upregulate various cellular processes, potentially including the expression or stabilization of C10orf88 if linked to energy homeostasis. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a CDK inhibitor that could lead to altered cell cycle progression. By inhibiting certain CDKs, it can influence the transcription and stability of numerous proteins, potentially enhancing the expression or function of C10orf88 if its regulation is cell cycle-dependent. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which modulates various cellular pathways, including transcription factors and cell cycle regulators. PKC activation could increase C10orf88 activity if PKC directly phosphorylates C10orf88 or modulates its regulators. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through its nuclear receptors. This can lead to changes in the expression of a wide array of proteins, possibly inducing C10orf88 if it is under retinoic acid-responsive elements. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that leads to chromatin remodeling and can affect the expression of genes. If C10orf88 expression is epigenetically regulated, sodium butyrate could enhance its transcription. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP acts as a cAMP analog, stimulating PKA and modulating the cAMP response element-binding (CREB) pathway. CREB influences the transcription of numerous genes, potentially including C10orf88 if it contains cAMP response elements. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3β indirectly promoting the activity of β-catenin signaling. If C10orf88 is associated with the β-catenin pathway, its activity or expression may be indirectly enhanced. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK and mimics cellular energy depletion, leading to a broad alteration of energy metabolism and possibly affecting proteins linked to metabolic regulation, such as C10orf88 if it plays a role in this context. | ||||||